Immunology of Helicobacter pylori and prospects for vaccine

Gastroenterology Clinics of North America

Volumn 29, Issue 3, 2000, Pages 671-685

  Blanchard, Thomas G ^a   Czinn, Steven J ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; CATALASE; CHOLERA TOXIN; ESCHERICHIA COLI ENTEROTOXIN; FREUND ADJUVANT; HELICOBACTER PYLORI VACCINE; SAPONIN; UNCLASSIFIED DRUG; UREASE; VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; CELLULAR IMMUNITY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; ERADICATION THERAPY; FERRET; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; IMMUNE RESPONSE; IMMUNOTHERAPY; MOUSE; NONHUMAN; PROPHYLAXIS; REVIEW; STOMACH DISEASE; STOMACH MUCOSA; STOMACH PROTECTION; SWINE; VACCINATION;

EID: 0033799491     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8553(05)70137-0     Document Type: Article

References (85)

1. Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity
2. Lipopolysaccharide of the Helicobacter pylori type strain NCTC 11637 (ATCC 43504): Structure of the O antigen and core oligosaccharide regions
3. Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype
4. Helicobacter pylori infection in patients with acquired immune deficiency syndrome
5. Experience with 'triple' anti-Helicobacter eradication therapy: Side effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance
6. Stimulatory effects of Helicobacter pylori on human peripheral blood mononuclear cells of H. pylori infected patients and healthy blood donors
7. Urease-specific monoclonal antibodies prevent Helicobacter felis infection in mice
8. Antibody-independent protective mucosal immunity to gastric Helicobacter infection in mice
9. Systemic vaccination inducing either Th1 or Th2 immunity protects mice from challenge with H. pylori
10. Recombinant cholera toxin B subunit is not an effective mucosal adjuvant for oral immunization of mice against H. felis
11. Qualitative and quantitative analysis of the local and systemic antibody responses in mice and humans with Helicobacter immunity and infection
12. Antimicrobial therapy as an adjunct to oral immunization significantly enhances the resolution of gastritis
13. Site-specific mutagenesis of the catalytic subunit of cholera toxin: Substituting lysine forarginine 7 causes loss of activity
14. Immunization against gastric infection with Helicobacter species: First step in the prophylaxis of gastric cancer?
15. Site-directed mutagenic alteration of potential active-site residues of the A subunit of Escherichia coli Heat-labile enterotoxin
16. Human gastric carcinogenesis: A multistep and multifactorial process-first American Cancer Society award lecture on cancer epidemiology and prevention
17. Oral immunization with Helicobacter pylori urease B subunit as a treatment against Helicobacter infection in mice
18. Mice are protected from Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhimurium phoPc expressing urease A and B subunits
19. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology
20. Therapeutic immunization against Helicobacter mustelae infection in naturally infected ferrets
21. Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization
22. Serum IgG antibody to the outer membrane proteins of Campylobacter pylori in children with gastroduodenal disease
23. Oral immunization against Helicobacter pylori
24. Different cytokine profile and antigen-specificity repertoire in Helicobacter pylori-specific T cell clones from the antrum of chronic gastritis patients with or without peptic ulcer
25. + T-cell clones from peripheral blood and gastric biopsies
26. Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity
27. Therapeutic immunization against Helicobacter infection
28. Mutants of Escherichia coli heat labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants
29. Immunization against natural Helicobacter pylori infection in nonhuman primates
30. Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets
31. Chronic active gastritis due to Helicobacter pylori in immunized Gnotobiotic piglets
32. Motility as a factor in the colonization of gnotobiotic piglets by Helicobacter pylori
33. Vaccination of gnotobiotic piglets against Helicobacter pylori
34. Mucosal adjuvants
35. Gastritis in urease-immunized mice after Helicobacter felis challenge may be due to residual bacteria
36. Interferon-gamma and tumor necrosis factor production in patients with Helicobacter pylori infection
37. Gastric T lymphocyte responses to Helicobacter pylori colonization
38. Recombinant antigens prepared from the urease subunits of Helicobacter spp.: Evidence of protection in a mouse model of gastric infection
39. The groES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice
40. Gastric colonization by Campylobacter pylori subsp. mustelae in ferrets
41. Helicobacter mustelae-associated gastritis in ferrets: An animal model of Helicobacter pylori gastritis in humans
42. Helicobacter mustelae-induced gastritis and elevated gastric pH in the ferret (Mustela putorius furo)
43. Therapeutic intragastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection
44. Protection of mice against gastric colonization by Helicobacter pylori by single oral dose immunization with attenuated Salmonella typhimurium producing urease subunits A and B
45. Systemic immunization with urease protects mice against Helicobacter pylori infection
46. Comparison between targeted and untargeted systemic immunizations with adjuvanted urease to cure Helicobacter pylori infection in mice
47. Differential stimulation of Interleukin-12 and IL-10 by live and killed Helicobacter pylori in vitro and association of IL-12 production with gamma interferon-producing T cells in the human gastric mucosa
48. Antibody responses in volunteers induced by nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin
49. Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems
50. Purification and N-terminal analysis of urease from Helicobacter pylori
51. Multiple strain colonization and metronidazole resistance in Helicobacter pylori-infected patients: Identification from sequential and multiple biopsy specimens
52. Helicobacter pylori induces lymphocyte activation in peripheral blood cultures
53. Interferon gamma and interleukin 4 secreting cells in the gastric antrum in Helicobacter pylori positive and negative gastritis
54. Expression of mRNA for interferon-gamma, interleukin-10, and interleukin-12 (p40) in normal gastric mucosa and in mucosa infected with Helicobacter pylori
55. Immunology of Helicobacter pylori
56. Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection
57. Role of the systemic cellular immune response in the pathogenesis of Helicobacter pylori-associated duodenal ulcer
58. Successful immunization against gastric infection with Helicobacter species: Use of a cholera toxin B-subunit-whole-cell vaccine
59. A standardized mouse model of Helicobacter pylori infection: Introducing the Sydney strain
60. Immunization with recombinant Helicobacter pylori urease decreases colonization levels following experimental infection of rhesus monkeys
61. Oral Immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis
62. Development of a mouse model of Helicobacter pylori infection that mimics human disease
63. Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a nontoxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant
64. Screening of anti-Helicobacter therapies in mice colonized with H. pylori
65. Resistance of Helicobacter pylori to antibiotics
66. Immunization of Balb/c mice against Helicobacter felis infection with Helicobacter pylori urease
67. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults
68. Helicobacter pylori infection induces antibodies cross-reacting with human gastric mucosa
69. Protective immunization against Helicobacter stimulates long-term immunity
70. Catalase: A novel antigen for Helicobacter pylori vaccination
71. Systematic and local antibody responses to gastric Campylobacter pyloridis in non-ulcer dyspepsia
72. Reasons for failure of Helicobacter pylori treatment
73. Vaccine strategies for prevention of Helicobacter pylori infections
74. Humoral and cellular immune recognition of Helicobacter pylori proteins are not concordant
75. Typing of Helicobacter pylori with monoclonal antibodies against Lewis antigens in lipopolysaccharide
76. Medical treatment of peptic ulcer disease: Practice guidelines
77. Synergistic action of cholera toxin B subunit (and Escherichia coli heat-labile toxin B subunit) and a trace amount of cholera whole toxin as an adjuvant for nasal influenza vaccine
78. Cell-mediated immune responsiveness to Helicobacter pylori in healthy seropositive and seronegative adults
79. Unidentified curved bacilli on gastric epithelium in active chronic gastritis
80. Novel intranasal immunization techniques for antibody induction and protection of mice against gastric Helicobacter felis infection
81. Promotion of ulcerative duodenitis in young ferrets by oral immunization with Helicobacter mustelae and muramyl dipeptide
82. Whole cholera toxin and B subunit act synergistically as an adjuvant for the mucosal immune response of mice to keyhole limpet haemocyanin
83. Expression of the human cell surface glycoconjugates Lewis X and Lewis Y by Helicobacter pylori isolates is related to cagA status
84. A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity